JinekM, ChylinskiK, FonfaraI, et al.A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science. 2012; 337:816–821. DOI: 10.1126/science.1225829.
2.
NurkS, KorenS, RhieA, et al.The complete sequence of a human genome. Science. 2022; 376:44–53. DOI: 10.1126/science.abj6987.
3.
CongL, RanFA, CoxD, et al.Multiplex genome engineering using CRISPR/Cas systems. Science. 2013; 339:819–823. DOI: 10.1126/science.1231143.
4.
MaliP, YangL, EsveltKM, et al.RNA-guided human genome engineering via Cas9. Science. 2013; 339:823–826. DOI: 10.1126/science.1232033.
5.
FrangoulH, AltshulerD, CappelliniMD, et al.CRISPR-Cas9 gene editing for sickle cell disease and β-thalassemia. N Engl J Med. 2021; 384:252–260. DOI: 10.1056/NEJMoa2031054.
6.
GillmoreJD, GaneE, TaubelJ, et al.CRISPR-Cas9 in vivo gene editing for transthyretin amyloidosis. N Engl J Med. 2021; 385:493–502. DOI: 10.1056/NEJMoa2107454.
7.
SherkowJS. Immaculate conception? Priority and invention in the CRISPR patent dispute. CRISPR J. 2022; 5:174–180. DOI: 10.1089/crispr.2022.0033.
